Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “B-cell Precursor Acute Lymphoblastic Leukaemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT03564470
What this trial is testing

Precision Diagnosis Directing HDACi and TKI Target Therapy for Adult Ph-like ALL

Who this might be right for
LeukemiaLeukemia, AcuteLeukemia, Lymphoblastic+1 more
Nanfang Hospital, Southern Medical University 120
Early research (Phase 1)Study completedNCT00049686
What this trial is testing

VNP40101M in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndrome

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
Vion Pharmaceuticals
Not applicableStudy completedNCT00956475
What this trial is testing

Quality of Life in Younger Leukemia and Lymphoma Survivors

Who this might be right for
Anxiety DisorderCancer SurvivorFatigue+7 more
Case Comprehensive Cancer Center 48
Not applicableLooking for participantsNCT06481228
What this trial is testing

Efficacy and Safety of TKI Combined With Chemotherapy and Sequential CAR-T Cells in ND Adult Patients With Ph+ ALL

Who this might be right for
Philadelphia Positive Acute Lymphoblastic LeukemiaAcute Lymphoblastic Leukemia, Adult
Institute of Hematology & Blood Diseases Hospital, China 82
Testing effectiveness (Phase 2)Study completedNCT01471782
What this trial is testing

Clinical Study With Blinatumomab in Pediatric and Adolescent Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia
Amgen Research (Munich) GmbH 93
Early research (Phase 1)UnknownNCT05038696
What this trial is testing

ALaCART-B: Acute Leukemia and Chimeric Antigen Receptor-T Cell Therapy for B-lymphoblastic Leukemia.

Who this might be right for
Lymphoblastic Leukemia, Acute, ChildhoodLymphoblastic LeukemiaLymphoblastic Leukemia, Acute Adult+3 more
National University Hospital, Singapore 40
Testing effectiveness (Phase 2)Study completedNCT01842672
What this trial is testing

Mitoxantrone and Clofarabine for Treatment of Recurrent NHL or Acute Leukemia

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaLymphoblastic Lymphoma+2 more
New York Medical College 41
Early research (Phase 1)UnknownNCT04037566
What this trial is testing

CRISPR (HPK1) Edited CD19-specific CAR-T Cells (XYF19 CAR-T Cells) for CD19+ Leukemia or Lymphoma.

Who this might be right for
Leukemia Lymphocytic Acute (ALL) in RelapseLeukemia Lymphocytic Acute (All) RefractoryLymphoma, B-Cell+1 more
Xijing Hospital 40
Early research (Phase 1)Looking for participantsNCT06593145
What this trial is testing

CAR T Cells in the Treatment of Refractory and Relapsed CD19+ B Cell Neoplasms

Who this might be right for
Acute Lymphoblastic Leukemia (ALL)Mantle Cell Lymphoma (MCL)Large B-cell Lymphoma
FamiCordTx 6
Large-scale testing (Phase 3)Looking for participantsNCT07152041
What this trial is testing

Newly-diagnosed Pediatric Ph-positive B-ALL Protocol

Who this might be right for
Acute Lymphoblastic Leukemia (ALL) Philadelphia Chromosome-positive (Ph+)Childhood Leukemia, Acute Lymphoblastic
Institute of Hematology & Blood Diseases Hospital, China 150
Not applicableStudy completedNCT00993694
What this trial is testing

Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+6 more
Vanderbilt University 41
Early research (Phase 1)Ended earlyNCT00068302
What this trial is testing

Sirolimus in Treating Young Patients With Relapsed or Refractory Acute Leukemia or Non-Hodgkin's Lymphoma

Who this might be right for
LeukemiaLymphoma
Children's Hospital of Philadelphia 10
Testing effectiveness (Phase 2)Study completedNCT02208037
What this trial is testing

Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203)

Who this might be right for
Acute LeukemiaChronic Myelogenous LeukemiaMyelodysplasia+6 more
National Heart, Lung, and Blood Institute (NHLBI) 279
Testing effectiveness (Phase 2)Ended earlyNCT00276159
What this trial is testing

Study of Immune Response Modifier in the Treatment of Hematologic Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaNon-Hodgkin's Lymphoma+3 more
Masonic Cancer Center, University of Minnesota 6
Testing effectiveness (Phase 2)Ended earlyNCT02129062
What this trial is testing

Ibrutinib in Treating Patients With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia

Who this might be right for
Adult B Acute Lymphoblastic LeukemiaAdult B Acute Lymphoblastic Leukemia With t(9;22)(q34;q11.2); BCR-ABL1Recurrent Adult Acute Lymphoblastic Leukemia
National Cancer Institute (NCI) 3
Testing effectiveness (Phase 2)Study completedNCT00467961
What this trial is testing

Stem Cell Transplantation for Patients With Cancers of the Blood

Who this might be right for
CML (Chronic Myelogenous Leukemia)CLL (Chronic Lymphocytic Leukemia)AML (Acute Myelogenous Leukemia)+2 more
National Heart, Lung, and Blood Institute (NHLBI) 61
Testing effectiveness (Phase 2)Looking for participantsNCT05082519
What this trial is testing

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

Who this might be right for
B-cell Acute Lymphoblastic LeukemiaObesity
Etan Orgel 240
Early research (Phase 1)Ended earlyNCT03878524
What this trial is testing

Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAnatomic Stage IV Breast Cancer AJCC v8Anemia+47 more
OHSU Knight Cancer Institute 2
Testing effectiveness (Phase 2)UnknownNCT03366324
What this trial is testing

Anti-CD19 CAR-T Therapy Combine With HSCT to Treat MRD+ B-cell Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiaB Cell Lymphoma
Wuhan Sian Medical Technology Co., Ltd 20
Early research (Phase 1)Study completedNCT00640796
What this trial is testing

Pilot Study of Expanded, Donor Natural Killer Cell Infusions for Refractory Non-B Lineage Hematologic Malignancies and Solid Tumors

Who this might be right for
Leukemia, Myeloid, AcuteLeukemia, Lymphocytic, Acute, T-CellJuvenile Myelomonocytic Leukemia Lymphoblastic+2 more
St. Jude Children's Research Hospital 22
Next Page